Microdosing Research: What Imperial College London Actually Found
About This Video
Researchers from Imperial College London present the results of their pre-registered observational study on microdosing — one of the most carefully designed investigations into whether microdosing produces the effects users report. The methodology is important context: this was not a randomized controlled trial but an observational study of self-identified microdosers, compared to matched controls. The findings show improvements in wellbeing and psychological functioning in microdosers compared to controls — but the researchers are careful to note that the expectancy effect (placebo) is very difficult to separate from genuine pharmacological effect in this design. The same team's self-blinding RCT design is discussed as the next step. This video is valuable for understanding both what the research shows and why the design limitations matter.
Key Takeaways
- Observational study shows improvements in wellbeing and psychological functioning in microdosers vs. controls.
- The expectancy (placebo) effect is substantial and very difficult to control in observational designs.
- Mood and anxiety benefits appear more consistent in the data than cognitive performance benefits.
- Imperial researchers designed a self-blinding RCT as a follow-up to better separate placebo from pharmacological effect.
- The research is promising but early — caution is warranted before strong conclusions about efficacy.